Cancer Family
Carcinoma
CI-CAN-00000114Explore in graph →
7,369 active trials118 approved drugs1,149 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000114Explore in graph →
Clinical trials
25,729 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (3,405)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00425191 | Taxotere Combinations as First Line Therapy for Locally Advanced Unresectable or Metastatic Non-small Cell Lung Cancer. | completed | Phase 2 | 165 | SanofiINDUSTRY | 1 | Dec 7, 2009 | clinicaltrials |
| NCT00099541 | Non-small Cell Lung Cancer Registry | completed | Phase 4 | 300 | Novartis PharmaceuticalsINDUSTRY | 1 | Nov 23, 2009 | clinicaltrials |
| NCT01018381 |
| Arabinoxylan Rice Bran (MGN-3/Biobran) for the Treatment of Hepatocellular Carcinoma and Hepatitis B and C Infection |
| completed |
| N/A |
| 130 |
| The 108 Military Central HospitalOTHER_GOV |
| 1 |
| Nov 23, 2009 |
| clinicaltrials |
| NCT01015898 | Short Term Effects of Photodynamic Therapy in Basal Cell Carcinoma | completed | Phase 1 | 28 | Shahid Beheshti University of Medical SciencesOTHER | 0 | Nov 18, 2009 | clinicaltrials |
| NCT00137761 | Docetaxel in Combination With Iressa in Previously Treated Patients With Pancreatic Cancer | completed | Phase 2 | 32 | Dana-Farber Cancer InstituteOTHER | 1 | Nov 2, 2009 | clinicaltrials |
| NCT00165126 | Dosimetric Analysis of Vaginal Cuff Brachytherapy in Endometrial Carcinoma | completed | — | 40 | Dana-Farber Cancer InstituteOTHER | 1 | Nov 2, 2009 | clinicaltrials |
| NCT01004601 | Low Dose Weekly Docetaxel Versus Pemetrexed in Previously Treated Advanced Non-Small-Cell Lung Cancer | completed | N/A | 179 | Chang Gung Memorial HospitalOTHER | 1 | Oct 30, 2009 | clinicaltrials |
| NCT00363415 | Study of Pemetrexed and Carboplatin Compared With Etoposide Carboplatin to Treat Extensive-Stage Small Cell Lung Cancer | completed | Phase 3 | 908 | Eli Lilly and CompanyINDUSTRY | 26 | Oct 28, 2009 | clinicaltrials |
| NCT00370292 | Dosage Schedule Study of Pemetrexed Monochemotherapy for Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 19 | Eli Lilly and CompanyINDUSTRY | 1 | Oct 20, 2009 | clinicaltrials |
| NCT00997633 | Single-photon Emission Computed Tomography (SPECT) to Predict Peritoneal Chemotherapy | completed | — | 51 | Uppsala UniversityOTHER | 1 | Oct 19, 2009 | clinicaltrials |
| NCT00212043 | Phase I/II Trial of Infusional Gemcitabine in Combination With Carboplatin in Chemonaive Non-small Cell Carcinoma | completed | Phase 2 | 74 | National University Hospital, SingaporeOTHER | 0 | Oct 8, 2009 | clinicaltrials |
| NCT00988455 | Evaluation of Efficacy of Photodynamic Therapy in Basal Cell Carcinoma With 6 Months Follow-up | completed | Phase 1 / Phase 2 | 28 | Shahid Beheshti University of Medical SciencesOTHER | 0 | Oct 2, 2009 | clinicaltrials |
| NCT00868725 | Detecting Lesions in the Oral Cavity With Thermal Imaging | completed | — | 50 | Sheba Medical CenterOTHER_GOV | 1 | Oct 1, 2009 | clinicaltrials |
| NCT00137423 | Study Of SU011248 (Sunitinib) Given In A Continuous Daily Regimen In Patients With Advanced Renal Cell Cancer | completed | Phase 2 | 107 | PfizerINDUSTRY | 7 | Sep 30, 2009 | clinicaltrials |
| NCT00319969 | Study Comparing Amrubicin Versus Topotecan in Patients With Small Cell Lung Cancer Who Have Responded to Prior Therapy. | completed | Phase 2 | 76 | Celgene CorporationINDUSTRY | 1 | Sep 30, 2009 | clinicaltrials |
| NCT00280618 | Oxaliplatin in Unresectable Hepatocellular Carcinoma | completed | Phase 2 | — | SanofiINDUSTRY | 0 | Sep 15, 2009 | clinicaltrials |
| NCT00173836 | Swallowing Pattern of Patients With Nasopharyngeal Cancer Before and After Radiation Therapy: Longitudinal Study and Correction With Saliva Amount | completed | — | 122 | National Taiwan University HospitalOTHER | 1 | Sep 9, 2009 | clinicaltrials |
| NCT00630240 | Risk Factors for the Leakage of Anticancer Drugs to Systemic Circulation by Transcatheter Arterial Chemoembolization | completed | — | 53 | Kaohsiung Medical University Chung-Ho Memorial HospitalOTHER | 1 | Sep 1, 2009 | clinicaltrials |
| NCT00625768 | Study of AS1409 in Patients With Either Metastatic Renal Cell Carcinoma or Metastatic Malignant Melanoma | completed | Phase 1 | 13 | Antisoma ResearchINDUSTRY | 2 | Aug 25, 2009 | clinicaltrials |
| NCT00063219 | Study Evaluating MAC-321 in Non-small Cell Lung Cancer Refractory to Platinum-based Therapy | completed | Phase 2 | 48 | Wyeth is now a wholly owned subsidiary of PfizerINDUSTRY | 1 | Aug 21, 2009 | clinicaltrials |
| NCT00067548 | Study Evaluating EKB-569 in Advanced Non-Small Cell Lung Cancer | completed | Phase 2 | 44 | Wyeth is now a wholly owned subsidiary of PfizerINDUSTRY | 0 | Aug 21, 2009 | clinicaltrials |
| NCT00495846 | GH, IGF-I and Somatostatin Analogues in Hepatocellular Carcinoma(SS-HCC) | completed | Phase 2 / Phase 3 | 25 | Federico II UniversityOTHER | 1 | Aug 17, 2009 | clinicaltrials |
| NCT00769730 | Evaluation the Possible Influence of Transcatheter Arterial Chemoembolization on Hepatitis B Viral Replication | completed | — | 25 | Kaohsiung Medical University Chung-Ho Memorial HospitalOTHER | 1 | Aug 4, 2009 | clinicaltrials |
| NCT00264498 | Phase II Iressa & Carbo/Gem in NSCLC | completed | Phase 2 | 38 | AstraZenecaINDUSTRY | 1 | Aug 3, 2009 | clinicaltrials |
| NCT00945568 | Preoperative Oral Supplementation With Branched-Chain Amino Acids (BCAA) Improves Postoperative Quality of Life(KMS) | completed | N/A | 100 | Kochi UniversityOTHER | 1 | Jul 24, 2009 | clinicaltrials |
| NCT00165334 | Cetuximab and Vinorelbine in Elderly Subjects With Lung Cancer | completed | Phase 2 | 53 | Dana-Farber Cancer InstituteOTHER | 1 | Jul 22, 2009 | clinicaltrials |
| NCT00613652 | A Phase I, Dose-Escalation Study to Assess the Safety and Drug Levels in Blood of AZD4877 in Japanese Adult Patients | completed | Phase 1 | 30 | AstraZenecaINDUSTRY | 1 | Jul 21, 2009 | clinicaltrials |
| NCT00350753 | Avastin and Tarceva for Upper Gastrointestinal Cancers | completed | Phase 2 | 126 | Rigshospitalet, DenmarkOTHER | 1 | Jul 15, 2009 | clinicaltrials |
| NCT00107861 | Interferon-Beta Gene Transfer (Ad.hIFN-β) as Treatment for Refractory Colorectal Carcinoma With Liver Metastases | completed | Phase 1 / Phase 2 | 44 | BiogenINDUSTRY | 1 | Jul 14, 2009 | clinicaltrials |
| NCT00495924 | Perioperative Cancer Cell Dissemination and Systemic Immune Suppression in Resectable Ductal Pancreatic Adenocarcinoma | completed | — | 100 | KU LeuvenOTHER | 1 | Jul 8, 2009 | clinicaltrials |
| NCT00464919 | Sorafenib Plus Tegafur/Uracil (UFUR®) for Hepatocellular Carcinoma (HCC) | completed | Phase 2 | 50 | National Taiwan University HospitalOTHER | 1 | Jul 7, 2009 | clinicaltrials |
| NCT00644254 | The Prognostic Impact of Extracapsular Lymph Node Involvement in Ductal Pancreatic Adenocarcinoma(ECLNI DPAC) | completed | — | 145 | KU LeuvenOTHER | 1 | Jul 7, 2009 | clinicaltrials |
| NCT00181506 | HI-CHART:Feasibility of High-Dose Accelerated Conformal Radiotherapy | completed | Phase 1 / Phase 2 | 180 | Maastricht Radiation OncologyOTHER | 1 | Jun 30, 2009 | clinicaltrials |
| NCT00181532 | Phase II Study of Celecoxib and Concurrent Radiotherapy in Stage II-III NSCLC | completed | Phase 2 | 102 | Maastricht Radiation OncologyOTHER | 1 | Jun 30, 2009 | clinicaltrials |
| NCT00181545 | Safety Study of Individualised Radiation Dose Determination for Lung Cancer Patients. | completed | Phase 1 | 30 | Maastricht Radiation OncologyOTHER | 1 | Jun 30, 2009 | clinicaltrials |
| NCT00044538 | Evaluation of BAY 59-8862 in Taxane Resistant Non-Small Cell Lung Cancer Patients | completed | Phase 2 | 102 | BayerINDUSTRY | 6 | Jun 22, 2009 | clinicaltrials |
| NCT00572923 | Concurrent Chemo-Radiotherapy for Limited Disease Small Cell Lung Cancer (LD-SCLC) on Basis of FDG-PET-Scans(BRONC 45 15) | completed | — | 52 | Maastricht Radiation OncologyOTHER | 1 | Jun 17, 2009 | clinicaltrials |
| NCT00034164 | Safety and Efficacy of S-8184 in Second Line Treatment of Relapsed Stage IIIB or IV Non Small Cell Lung Cancer | completed | Phase 2 | 52 | Achieve Life SciencesINDUSTRY | 1 | Jun 4, 2009 | clinicaltrials |
| NCT00077688 | TOCOSOL(TM) Paclitaxel in Metastatic or Locally Advanced Unresectable Transitional Cell Carcinoma of the Urothelium | completed | Phase 2 | 44 | Achieve Life SciencesINDUSTRY | 1 | Jun 4, 2009 | clinicaltrials |
| NCT00106002 | Pemetrexed as the First Treatment in Advanced or Metastatic Breast Cancer | completed | Phase 2 | 37 | Eli Lilly and CompanyINDUSTRY | 1 | Jun 1, 2009 | clinicaltrials |
| NCT00389285 | Study of Recombinant Interleukin 21 in Combination With Sorafenib for Metastatic Renal Cell Carcinoma | completed | Phase 1 / Phase 2 | 52 | ZymoGeneticsINDUSTRY | 1 | May 27, 2009 | clinicaltrials |
| NCT00167401 | Trial of Chemotherapy Followed by Pulsed Docetaxel and Concurrent Radiation for Non-Small Cell Lung Cancer | completed | Phase 2 | — | University of RochesterOTHER | 1 | May 19, 2009 | clinicaltrials |
| NCT00259987 | Effects Of Lapatinib (GW572016) In Patients With Relapsed Adenocarcinoma Of The Esophagus | completed | Phase 2 | 24 | GlaxoSmithKlineINDUSTRY | 3 | May 18, 2009 | clinicaltrials |
| NCT00591188 | Capecitabine and Interferon-Alpha in Metastatic Renal Cell Carcinoma Patients With Failure on Interleukin-2 Based Regimens | completed | Phase 2 | 49 | Kidney Cancer Research BureauOTHER | 1 | May 1, 2009 | clinicaltrials |
| NCT00102700 | ARQ 501 in Combination With Gemcitabine in Subjects With Pancreatic Cancer | completed | Phase 2 | 66 | ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)INDUSTRY | 1 | Apr 29, 2009 | clinicaltrials |
| NCT00099190 | ARQ 501 in Combination With Docetaxel in Patients With Cancer | completed | Phase 1 | 50 | ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)INDUSTRY | 1 | Apr 28, 2009 | clinicaltrials |
| NCT00165191 | Doxorubicin, Cisplatin, 5-Fluorouracil in Patients With Advanced Adenocarcinoma of the Stomach or Esophagus | completed | Phase 2 | 32 | Dana-Farber Cancer InstituteOTHER | 1 | Apr 28, 2009 | clinicaltrials |
| NCT00358930 | A Study of ARQ 501 in Patients With Squamous Cell Carcinoma of the Head and Neck | completed | Phase 2 | 60 | ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)INDUSTRY | 1 | Apr 28, 2009 | clinicaltrials |
| NCT00255476 | The IRESSA Novel Head and Neck Chemotherapy Evaluation Study | completed | Phase 2 | 64 | AstraZenecaINDUSTRY | 1 | Apr 23, 2009 | clinicaltrials |
| NCT00256711 | Phase II Iressa Versus Vinorelbine (INVITE) | completed | Phase 2 | 192 | AstraZenecaINDUSTRY | 10 | Apr 23, 2009 | clinicaltrials |
Data updated 23 days agoSource updated Dec 7, 2009source: clinicaltrials